Your browser doesn't support javascript.
loading
Levels of cytokines and GADA in type I and II diabetic patients.
Amin, Kawa; Qadr, Shnyar Hamid; Hassan Hussein, Ridha; Ali, Kosar Muhammad; Rahman, Heshu Sulaiman.
Afiliação
  • Amin K; Department of Medical Science, Respiratory Medicine and Allergology, Clinical Chemistry and Asthma Research Centre, Uppsala University and University Hospital, Uppsala, Sweden; Department of Microbiology/Immunology, College of Medicine, University of Sulaimani, Sulaimani, Iraq. Electronic address: k
  • Qadr SH; Department of Clinical Biochemistry, College of Pharmacy, University of Sulaimani, Iraq.
  • Hassan Hussein R; Department of Biology, College of Science, University of Sulaimani, Iraq.
  • Ali KM; Department of Medicine, College of Medicine, University of Sulaimani, Sulaimani, Iraq.
  • Rahman HS; College of Veterinary Medicine, University of Sulaimani, Sulaimani, Iraq.
Prim Care Diabetes ; 14(1): 61-67, 2020 02.
Article em En | MEDLINE | ID: mdl-31014937
ABSTRACT

BACKGROUND:

Diabetes Mellitus is described as a group of metabolic diseases in which the patient has higher blood glucose levels due to many causes. These include a defect in insulin secretion and failure of the body's cells to respond to the hormone. Cytokines and autoantibodies have a critical role in the pathogenesis of diabetes, especially type I. AIM OF THE STUDY The aim of this study was to measure the serum levels of interleukin-1 beta (IL-1 ß), interleukin-3 (IL-3), interferon-gamma (INF- γ), and glutamic acid decarboxylase autoantibody (GADA) in patients with type I and type II diabetes mellitus. MATERIAL AND

METHODS:

In this cross-sectional study, serum samples were taken from 250 individuals, including 100 samples from patients with type II diabetes mellitus, 100 samples from healthy controls, and 50 samples from patients with type I diabetes mellitus. Five milliliters of venous blood were taken from each individual and the samples were analyzed for cytokines (IL-1 ß, IL-3, and INF- γ) and GABA using ELISA.

RESULTS:

In the study, we found that the serum levels of IL-1 ß were significantly higher in the healthy control group compared to the patients with type I and type II diabetes mellitus. The levels of IL-3 and INF- γ were significantly higher in type II diabetes mellitus, while GABA serum levels were higher in type I diabetes mellitus.

CONCLUSION:

Our data showed that GADA is an important autoantibody, not only in type I but also in type II diabetes mellitus and can probably be used in the future for diagnosis of this disease. There was also a close association of GADA with systemic immunoregulation in type I and II diabetes mellitus. The relation of cytokines (IL-1 ß, IL-3, and INF- γ) and GADA in patients with diabetes will also increase our understanding for the immunology of diabetes mellitus and to propose specific treatment on the basis of our findings. Our data also include correlation between age and the level of cytokines and GADA with different conclusion for each parameter.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Citocinas / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Glutamato Descarboxilase Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Prim Care Diabetes Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoanticorpos / Citocinas / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 / Glutamato Descarboxilase Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Prim Care Diabetes Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2020 Tipo de documento: Article
...